:: Volume 7, Issue 2 (3-2020) ::
JBRMS 2020, 7(2): 7-12 Back to browse issues page
The patterns of aminoglycoside and fluoroquinolones resistance among uropathogenic Escherichia coli isolates
Saeed Hemati , Morteza Shams , Arash Rahmatian, Hasan Nourmohammadi, Amir Abdoli, Farajolah Maleki, Ghasem Talee, Zahra Mahdavi, Elham Bastani, Vahid Hatami, Fatemeh Kohzadi
Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran
Abstract:   (848 Views)
Introduction: In the study we sought to determine the patterns of regional antibiotic resistances among uropathogenic Escherichia coli (UPEC) isolates. Our finding could be useful for better recognition of regional antibiotic resistances and scheduling a program to control this condition.
Materials and methods: In the study, 270 nonduplicate UPEC isolates were examined from urine samples of outpatients with urinary tract infections (UTIs). All isolates were identified by gram staining and standard conventional biochemical tests. Antimicrobial susceptibility test was performed by disk diffusion (Kirby–Bauer) method. The commercial antibiotics disks (PADTAN TEB Co., Iran) were applied in the study, included amikacin (30 μg), gentamycin (10 μg), ciprofloxacin (5 μg), and nalidixic acid (30 μg).
Results: Most of the patients were female (221, 81.9%). The highest resistance was observed for nalidixic acid (56%), followed by ciprofloxacin 39.64%. In contrast, the lowest resistance was seen for amikacin (3.90%) and gentamicin (10.04%). Moreover, 19.62% of the isolates were multidrug-resistant (MDR).
Conclusion: Amikacin and gentamicin could be chosen as first line antibiotics in treatment of UTIs. Continuous monitoring studies recommended for acquire a suitable regional antibiotic resistance pattern.
Keywords: Escherichia coli, UTIs, Antimicrobial susceptibility
Full-Text [PDF 464 kb]   (387 Downloads)    
Type of Study: Research | Subject: Microbiology
Received: 2020/02/11 | Accepted: 2020/05/26 | Published: 2020/03/1


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 2 (3-2020) Back to browse issues page